Crossmark

A computational clinical decision-supporting system to suggest effective anti-epileptic drugs for pediatric epilepsy patients based on deep learning models using patient’s medical history

Crossref DOI link: https://doi.org/10.1186/s12911-024-02552-w

Published Online: 2024-05-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cho, Daeahn

Yu, Myeong-Sang

Shin, Jeongyoon

Lee, Jingyu

Kim, Yubin

Kang, Hoon-Chul

Kim, Se Hee

Na, Dokyun https://orcid.org/0000-0002-9107-7040
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2023R1A2C1008156)

Bio & Medical Technology Development Program of the National Research Foundation (2024)
License Information

Text and Data Mining valid from 2024-05-31

Version of Record valid from 2024-05-31
More Information

Article History

Received: 9 April 2023

Accepted: 21 May 2024

First Online: 31 May 2024

Declarations

:

: The study protocol was approved by the Institutional Review Board of Yonsei University Health System (IRB number: 4-2021-1163).

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below